[Carcinostasis with heterocyclic derivatives of 2-amino-1,4-naphthoquinone in transplantation-tumors].
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D006224:Cricetinae; D007958:Leukocyte Count; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D051379:Mice; D009285:Naphthoquinones / Q000627:therapeutic use*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D012510:Sarcoma 180 / Q000188:drug therapy
D000970:Antineoplastic Agents; D009285:Naphthoquinones
Carcinostase durch heterocyclische Derivate des 2-amino-1,4-naphthochinons bei Transplantations-Tumoren.